Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;8(1):14-7.
doi: 10.1046/j.1542-474x.2003.08103.x.

Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety

Mete Alpaslan  1 , Ersel Onrat, Murat Samli, Cetin Dincel
Affiliations

Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety

Mete Alpaslan et al. Ann Noninvasive Electrocardiol. 2003 Jan.

Abstract

Background: Sildenafil is an effective and widely used therapeutic agent for erectile dysfunction. Deaths have been reported due to sildenafil use and most of them are attributed to concurrent use of nitrates. However, the effects of sildenafil on QT intervals, QT dispersion, and the possible risk of ventricular arrhythmia have not been studied before. Our aim in this study was to evaluate the effect of sildenafil citrate on QT intervals and QT dispersion.

Methods: Thirty-six patients with erectile dysfunction were included in this study. Twenty-one patients had coronary artery disease whereas 12 of them also had accompanying diabetes mellitus. Standard 12-lead electrocardiograms (ECG) were recorded three times: before, and at the first and fourth hours of 50 mg sildenafil citrate ingestion. All QT parameters were corrected for heart rate.

Results: Mean age of the patients was 54 +/- 12 years. The mean heart rate did not differ significantly between the three ECG examinations. The corrected and uncorrected maximum and minimum QT intervals were not significantly different between the three ECG examinations. The QT dispersion and corrected QT dispersion before and 1 hour and 4 hours after sildenafil ingestion were 31 +/- 9 ms, 36 +/- 10 ms; 32 +/- 11 ms, 37 +/- 14 ms; 27 +/- 8 ms, 32 +/- 9 ms, respectively (P > 0.05).

Conclusions: Sildenafil does not prolong QT intervals or increase QT dispersion in patients with erectile dysfunction. Our results suggest that the risk of ventricular arrhythmia does not increase with ingestion of 50 mg sildenafil.

PubMed Disclaimer

References

    1. Kloner RA. Erectile dysfunction and cardiovascular risk factors. Hosp Pract 2001;36: 41–4,49–51. - PubMed
    1. Kloner RA. Hypertension as a risk for erectile dysfunction: Implications for sildenafil use. J Clin Hypertens 2000;2: 33–36. - PubMed
    1. Manecke RG, Mulhall JP. Medical treatment of erectile dysfunction. Ann Med 1999;31: 388–398. - PubMed
    1. Boolell M, Allen MJ, Ballard SA, et al Sildenafil: An orally active type 5 cyclic GMP‐specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8: 47–52. - PubMed
    1. Ballard SA, Gingell CJ, Tang K, et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998;159: 2164–2171. - PubMed

Publication types

LinkOut - more resources